Markets /Healthcare /IMNP Immune Pharmaceuticals, Inc. IMNP Full chart Compare Add to watchlist Set alert Price alert · IMNP Alert when the price is Price abovePrice below Price level Set alert All alert types 0.00 0.00 (-39.62%) 0.0023 Day range 0.0051 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2014FY 2013 Other Operating Income → Expenses: $3.40MExpenses → Gross Loss: $18.00KExpenses → Selling, General & Admin: $10.72MExpenses → Research & Development: $5.64MExpenses → Interest Expense: $3.40MExpenses → Other Expenses: $7.17MNet Loss → Expenses: $23.55MRevenue → Cost of Revenue: $2.00KOther Operating Income$3.40MNet Loss$23.55MCost of Revenue$20.00KExpenses$26.95MGross Loss$18.00KSelling, General & Admin$10.72MResearch & Development$5.64MInterest Expense$3.40MOther Expenses$7.17MRevenue$2.00K No annual statement lines IMNP has no annual lines for this statement.
